Global Angina Pectoris Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Nitrates, Angiotensin-converting Enzyme Inhibitors (ACE Inhibitors), Anti-Platelets, Others), By End Users (Hospital, Speciality Clinics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 - 2030

Industry: Healthcare
RELEASE DATE Apr 2023
REPORT ID SI1645
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Drug Class
      2. Market Attractiveness Analysis by End Users
      3. Market Attractiveness Analysis by Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing geriatric population
    3. Restraints
      1. High cost of therapy
    4. Opportunities
      1. Emerging technologies
    5. Challenges
      1. Increasing Cost of drugs
  6. Global Angina Pectoris Drugs Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Beta Blockers
    3. Calcium Channel Blockers
    4. Nitrates
    5. Angiotensin-converting Enzyme Inhibitors
    6. Anti-Platelets
    7. Others
  7. Global Angina Pectoris Drugs Market Analysis and Projection, By End Users
    1. Hospital
    2. Speciality Clinics
    3. Others
  8. Global Angina Pectoris Drugs Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Angina Pectoris Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Angina Pectoris Drug Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Abbott Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. AERIE PHARMACEUTICALS, INC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Abbvie, INC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Bausch Health Companies, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. Merck & Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Amorphex Therapeutics Holdings, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Alcon
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10. Astellas Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13. Astrazeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14. Amgen INC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Gilead Sciences, INC.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    16. Sun Pharmaceutical Industries, Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    17. Hoffmann-La Roche Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    18. Zydus Healthcare
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  2. Global Beta Blockers, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  3. Global Calcium Channel Blockers, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  4. Global Nitrates, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  5. Global Angiotensin-converting Enzymes, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  6. Global Anti-Platelets, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  7. Global Others, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  8. Global Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  9. Global Hospitals, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  10. Global Speciality Clinics, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  11. Global Others, Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  12. Global Angina Pectoris Drugs Market, By Region, 2022-2030(USD Billion)
  13. North America Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  14. North America Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  15. U.S. Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  16. U.S. Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  17. Canada Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  18. Canada Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  19. Mexico Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  20. Mexico Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  21. Europe Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  22. Europe Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  23. Germany Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  24. Germany Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  25. France Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  26. France Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  27. U.K. Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  28. U.K. Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  29. Italy Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  30. Italy Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  31. Spain Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  32. Spain Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  33. Asia Pacific Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  34. Asia Pacific Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  35. Japan Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  36. Japan Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  37. China Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  38. China Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  39. India Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  40. India Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  41. South America Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  42. South America Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  43. Brazil Angina Pectoris Drugs Market, By Drug Class, 2022-2030(USD Billion)
  44. Brazil Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  45. The Middle East and Africa Angina Pectoris Drugs Market, Drug Class, 2022-2030(USD   Billion)
  46. The Middle East and Africa Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)
  47. UAE Angina Pectoris Drugs Market, Drug Class, 2022-2030(USD Billion)
  48. UAE Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion) 
  49. South Africa Angina Pectoris Drugs Market, Drug Class, 2022-2030(USD Billion)
  50. South Africa Angina Pectoris Drugs Market, By End Users, 2022-2030(USD Billion)

 

List of Figures 

  1. Global Angina Pectoris Drugs Market Segmentation
  2. Angina Pectoris Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Angina Pectoris Drugs Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Angina Pectoris Drugs Market
  20. Angina Pectoris Drugs Market Segmentation, By Drug Class
  21. Angina Pectoris Drugs Market, For Beta Blockers, By Region, 2022-2030 ($ Billion)
  22. Angina Pectoris Drugs Market, For Calcium Channel Blockers, By Region, 2022-2030 ($ Billion)
  23. Angina Pectoris Drugs Market, For Nitrates, By Region, 2022-2030 ($ Billion)
  24. Angina Pectoris Drugs Market, For Angiotensin-converting Enzyme Inhibitors, By Region, 2022-2030 ($ Billion)
  25. Angina Pectoris Drugs Market, For Anti-Platelets, By Region, 2022-2030 ($ Billion)
  26. Angina Pectoris Drugs Market, For Others, By Region, 2022-2030 ($ Billion)
  27. Angina Pectoris Drugs Market Segmentation, By End Users
  28. Angina Pectoris Drugs Market, For Hospital, By Region, 2022-2030 ($ Billion)
  29. Angina Pectoris Drugs Market, For Speciality Clinic, By Region, 2022-2030 ($ Billion)
  30. Angina Pectoris Drugs Market, For Others, By Region, 2022-2030 ($ Billion)
  31. Abbott Laboratories: Net Sales, 2022-2030 ($ Billion)
  32. Abbott Laboratories: Revenue Share, By Segment, 2022 (%)
  33. Abbott Laboratories: Revenue Share, By Region, 2022 (%)
  34. AERIE PHARMACEUTICALS, INC: Net Sales, 2022-2030 ($ Billion)
  35. AERIE PHARMACEUTICALS, INC: Revenue Share, By Segment, 2022 (%)
  36. AERIE PHARMACEUTICALS, INC: Revenue Share, By Region, 2022 (%)
  37. Abbvie Inc: Net Sales, 2022-2030 ($ Billion)
  38. Abbvie Inc: Revenue Share, By Segment, 2022 (%)
  39. Abbvie Inc: Revenue Share, By Region, 2022 (%)
  40. Bausch Health Companies Inc: Net Sales, 2022-2030 ($ Billion)
  41. Bausch Health Companies Inc: Revenue Share, By Segment, 2022 (%)
  42. Bausch Health Companies Inc: Revenue Share, By Region, 2022 (%)
  43. Merck & Co. Inc.: Net Sales, 2022-2030 ($ Billion)
  44. Merck & Co. Inc.: Revenue Share, By Segment, 2022 (%)
  45. Merck & Co. Inc.: Revenue Share, By Region, 2022 (%)
  46. Pfizer Inc: Net Sales, 2022-2030 ($ Billion)
  47. Pfizer Inc: Revenue Share, By Segment, 2022 (%)
  48. Pfizer Inc: Revenue Share, By Region, 2022 (%)
  49. Teva Pharmaceutical Industries Ltd.: Net Sales, 2022-2030 ($ Billion)
  50. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2022 (%)
  51. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2022 (%)
  52. Amorphex Therapeutics Holdings, Inc: Net Sales, 2022-2030 ($ Billion)
  53. Amorphex Therapeutics Holdings, Inc: Revenue Share, By Segment, 2022 (%)
  54. Amorphex Therapeutics Holdings, Inc: Revenue Share, By Region, 2022 (%)
  55. Alcon: Net Sales, 2022-2030 ($ Billion)
  56. Alcon: Revenue Share, By Segment, 2022 (%)
  57. Alcon: Revenue Share, By Region, 2022 (%)
  58. Astellas Pharma Inc.: Net Sales, 2022-2030 ($ Billion)
  59. Astellas Pharma Inc.: Revenue Share, By Segment, 2022 (%)
  60. Astellas Pharma Inc.: Revenue Share, By Region, 2022 (%)
  61. Bayer AG: Net Sales, 2022-2030 ($ Billion)
  62. Bayer AG: Revenue Share, By Segment, 2022 (%)
  63. Bayer AG: Revenue Share, By Region, 2022 (%)
  64. Novartis AG.: Net Sales, 2022-2030 ($ Billion)
  65. Novartis AG: Revenue Share, By Segment, 2022 (%)
  66. Novartis AG: Revenue Share, By Region, 2022 (%)
  67. AstraZeneca: Net Sales, 2022-2030 ($ Billion)
  68. AstraZeneca: Revenue Share, By Segment, 2022 (%)
  69. AstraZeneca: Revenue Share, By Region, 2022 (%)
  70. Carl Zeiss Meditec AG: Net Sales, 2022-2030 ($ Billion)
  71. Carl Zeiss Meditec AG: Revenue Share, By Segment, 2022 (%)
  72. Carl Zeiss Meditec AG: Revenue Share, By Region, 2022 (%)
  73. Gilead Sciences, Inc: Net Sales, 2022-2030 ($ Billion)
  74. Gilead Sciences, Inc: Revenue Share, By Segment, 2022 (%)
  75. Gilead Sciences, Inc: Revenue Share, By Region, 2022 (%)
  76. Sun Pharmaceutical Industries Ltd: Net Sales, 2022-2030 ($ Billion)
  77. Sun Pharmaceutical Industries Ltd: Revenue Share, By Segment, 2022 (%)
  78. Sun Pharmaceutical Industries Ltd: Revenue Share, By Region, 2022 (%)
  79. F. Hoffmann-La Roche Ltd: Net Sales, 2022-2030 ($ Billion)
  80. F. Hoffmann-La Roche Ltd: Revenue Share, By Segment, 2022 (%)
  81. F. Hoffmann-La Roche Ltd: Revenue Share, By Region, 2022 (%)
  82. Zydus Healthcare: Net Sales, 2022-2030 ($ Billion)
  83. Zydus Healthcare: Revenue Share, By Segment, 2022 (%)
  84. Zydus Healthcare: Revenue Share, By Region, 2022 (%)

 

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:100
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:4.5%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies